title: Talimogene laherparepvec (Imlygic) for unresectable melanoma.
mesh_terms: D004347:Drug Interactions; D005260:Female; D005838:Genotype; D017048:Health Care Costs; D006801:Humans; D008545:Melanoma / Q000473:pathology / Q000628:therapy* / Q000821:virology; D050130:Oncolytic Virotherapy / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D050504:Oncolytic Viruses / Q000235:genetics*; D018579:Patient Selection; D011247:Pregnancy; D012307:Risk Factors; D018139:Simplexvirus / Q000235:genetics*; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy* / Q000821:virology; D016896:Treatment Outcome